CVS Health is adding four members to its board of directors following "productive discussions" with hedge fund investor Glenview Capital Management, the company said in a Nov. 18 news release.
Among those joining the board is Glenview CEO Larry Robbins, who said in the release the hedge fund welcomes the "opportunity to join the board, roll up our sleeves and lock arms with the Board and leadership team to drive long-term, sustainable value through continued customer-centric offerings, commitment to compliance and quality, disciplined underwriting and risk management, aligned incentives, and optimal capital allocation."
The others joining the board are Leslie Norwalk, Guy Sansone and Doug Shulman. The appointments expand the size of CVS Health's board to 16 members.
Ms. Norwalk serves as strategic counsel at the law firm Epstein Becker & Green, which focuses on healthcare, life sciences and workforce management solutions. She served as an acting administrator at CMS from 2001 to 2007. She will serve on the board's health services committee.
Mr. Sansone is CEO of H2 Health, a provider of physical rehabilitation and clinical staffing services. He will serve on the audit committee.
Mr. Shulman is the CEO of OneMain Financial, a personal and auto loan provider. He served as IRS commissioner from 2008 to 2012. He will serve on the management planning and development committee.
The appointments are the latest in a series of leadership moves CVS Health has made in recent months. CVS Health appointed David Joyner president and CEO Oct. 17, replacing Karen Lynch, who stepped down. Board Chair Roger Farah was named executive chair, Prem Shah was named group president and Steve Nelson was named president of Aetna.